Skip to main content
CriticalFDAfda-F-0841-2023UNDECLARED ALLERGEN

Multiple Vitamin B Capsules, 60 Capsules, Biologically Active Forms of Vitamin B12, Folate, B6. Packaged in bottles under the following ...

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
23,770
Recall Date
April 20, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0841-2023.

undeclared allergen (milk)

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0841-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Euro-pharma or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0841-2023.

Euro-Pharma

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Euro-pharma Recall FAQ

Euro-pharma is the subject of a supplements safety report: Multiple Vitamin B Capsules, 60 Capsules, Biologically Active Forms of Vitamin B12, Folate, B6. Packaged in bottles under the following .... The notice was published on April 20, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 23,770 units are potentially affected.